Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4107 results

Sort By:

Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

Study ID: NCT06902935
Start Date: 2025-04-26
End Date: 2027-04-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment

Diagnosis of Breast Cancer by Traditional Chinese Medicine Four Examinations

Ultrasound diagnosis of breast cancer

Sponsor

Taizhou Hospital

Source: clinicaltrials.gov

Share:
Add to list

Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression

Study ID: NCT06774235
Start Date: 2025-06-01
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

326

Intervention / Treatment

Interferon Gamma 1-b

Placebo

Sponsor

University Hospital, Limoges

Source: clinicaltrials.gov

Share:
Add to list

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

Study ID: NCT06819735
Start Date: 2025-06
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

DT-7012

Immune checkpoint inhibitor

Sponsor

Domain Therapeutics Australia Pty Ltd

Source: clinicaltrials.gov

Share:
Add to list

Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar

Study ID: NCT06857435
Start Date: 2025-06-30
End Date: 2028-10-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Full Thickness Skin Graft (FTSG)

Base of wound fat graft with Split Thickness Skin Graft (STSG) Reconstruction (Autologous Layered Composite Grafting).

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Study to Detect Dendritic Cell Recruitment in Human Retina

Study ID: NCT06872658
Start Date: 2025-05-01
End Date: 2026-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment
Sponsor

MindImmune Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

MethaLoad Dose-Finding Study

Study ID: NCT06877858
Start Date: 2025-09-01
End Date: 2027-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Methadone hydrochloride

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department

Study ID: NCT06315920
Start Date: 2026-05-01
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

226

Intervention / Treatment

Parecoxib

Morphine

Sponsor

Oman Medical Speciality Board

Source: clinicaltrials.gov

Share:
Add to list

A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Study ID: NCT06831058
Start Date: 2025-05-01
End Date: 2028-05-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

15

Intervention / Treatment

evangelical

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Ultrasound (US) Guided External Ventricular Catheter Placement

Study ID: NCT06253858
Start Date: 2025-07-01
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Catheter Placement with Solopass System

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus

Study ID: NCT05018858
Start Date: 2025-12
End Date: 2028-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

AlloRx

Sponsor

The Foundation for Orthopaedics and Regenerative Medicine

Source: clinicaltrials.gov

Share:
Add to list